Received Feb 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | 1965079 | — |
No additional AE. No PQC.; patient received an expired dose of GARDASIL 9.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-FEB-2026, the patient was vaccinated with expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (GARDASIL 9) (lot #1965079 has been verified as a valid lot #, expiration date was reported as 01-FEB-2026, 1 dosage form) for prophylaxis (Expired vaccine used). No adverse effects reported (No adverse event). This is one of two reports from the same reporter.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02941850-02941844 , CLIC number : , ESTAR number : , IRMS number : 500TP00000dyO2rYAE|03022026230027|5762 , Central date : 2026-02-04 , Classification : DMC, Attachment description : NSC Call , Safety case number : 2376818 , MNSC case number : 02941850 , MNSC interaction number : 02941844 , Integration log UniqueID : 500TP00000dyO2rYAE|03022026230027|5762 , Service cloud CaseID : 500TP00000dyO2rYAE